His primary areas of study are Surgery, Internal medicine, Liver transplantation, Transplantation and Gastroenterology. His biological study spans a wide range of topics, including Immunosuppression and Colorectal cancer, Oxaliplatin. His research integrates issues of Virus, Endocrinology and Oncology in his study of Internal medicine.
His Liver transplantation research also works with subjects such as
Wolf O. Bechstein mainly focuses on Internal medicine, Surgery, Liver transplantation, Transplantation and Gastroenterology. Wolf O. Bechstein has included themes like Endocrinology and Oncology in his Internal medicine study. His work in Surgery covers topics such as Urology which are related to areas like Renal function.
His Liver transplantation research is multidisciplinary, incorporating perspectives in Liver function, Survival rate, Incidence, Pathology and Tacrolimus. His Tacrolimus study frequently intersects with other fields, such as Ciclosporin. His work carried out in the field of Transplantation brings together such families of science as Immunosuppression, Immunology, Kidney and Complication.
Internal medicine, Surgery, Oncology, Liver transplantation and Chemotherapy are his primary areas of study. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Perioperative. His study on Surgery is mostly dedicated to connecting different topics, such as Cancer.
His Oncology research integrates issues from Gemcitabine and Pancreatic cancer. His Liver transplantation study deals with the bigger picture of Transplantation. His Chemotherapy study combines topics in areas such as Radiology, Stomach and Oxaliplatin, FOLFOX.
His main research concerns Surgery, Internal medicine, Chemotherapy, Oncology and Retrospective cohort study. His work in Surgery is not limited to one particular discipline; it also encompasses Cancer. His Internal medicine study typically links adjacent topics like Gastroenterology.
His Chemotherapy study combines topics from a wide range of disciplines, such as Randomized controlled trial, Perioperative, Radiofrequency ablation, FOLFOX and Colorectal cancer. His study on Oncology also encompasses disciplines like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.
Helmut Oettle;Stefan Post;Peter Neuhaus;Klaus Gellert.
JAMA (2007)
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Bengt Glimelius;Graeme J Poston.
The Lancet (2008)
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
Gunnar Folprecht;Thomas Gruenberger;Wolf O Bechstein;Hans-Rudolf Raab.
Lancet Oncology (2010)
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.
Sven Jonas;Wolf O. Bechstein;Thomas Steinmüller;Martin Herrmann.
Hepatology (2001)
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983) : long-term results of a randomised, controlled, phase 3 trial
Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Graeme J Poston.
Lancet Oncology (2013)
Extended resections for hilar cholangiocarcinoma.
Peter Neuhaus;Sven Jonas;Wolf O. Bechstein;Rüdiger Lohmann.
Annals of Surgery (1999)
Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.
Christoph Schuhmacher;Stephan Gretschel;Florian Lordick;Peter Reichardt.
Journal of Clinical Oncology (2010)
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Salah-Eddin Al-Batran;Nils Homann;Claudia Pauligk;Thorsten O Goetze.
The Lancet (2019)
Neurotoxicity of calcineurin inhibitors: impact and clinical management.
Wolf O. Bechstein.
Transplant International (2000)
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
T J Vogl;S Kümmel;R Hammerstingl;M Schellenbeck.
Radiology (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Charité - University Medicine Berlin
Goethe University Frankfurt
Goethe University Frankfurt
Goethe University Frankfurt
Charité - University Medicine Berlin
University of Erlangen-Nuremberg
Uppsala University
Queen Elizabeth Hospital Birmingham
University of Paris-Saclay
Leipzig University
Autonomous University of Madrid
Toronto Metropolitan University
Wuhan University
University of Copenhagen
Yokohama City University
Agency for Science, Technology and Research
Aarhus University
National Institute of Advanced Industrial Science and Technology
McMaster University
École Normale Supérieure de Lyon
Northeastern University
University of Western Australia
McMaster University
Washington University in St. Louis
University of Barcelona
Macquarie University